EnvironmentDot.com is an online directory for environment providing environment resources, water resources, vegetarianism, pollution prevention, agriculture, microbia, ozone and more.

Archive for the ‘Eco-Friendly’ Category

ADHD Medications: How ADHD Medicines Benefit Children with ADHD

Friday, July 20th, 2012

A minimum of 80 percent of children with ADHD respond positively to at least one of the stimulant ADHD medications available, according to the American Academy of Pediatrics (AAP). Stimulant ADHD medicines are the most frequently prescribed treatments for ADHD kids. Physicians frequently try multiple ADD medications to find the one that offers the best relief of ADHD symptoms with the least undesirable side effects.

Recently, physicians have found success with other types of ADHD medications, such as the non-stimulant drug, Strattera.

Available Stimulant ADHD Medications for Treating Children

Stimulant ADHD medications are divided into two classes: methylphenidate-based formulations and amphetamine-based formulations. Methylphenidate-based ADHD medicines include drugs sold under the brand names Ritalin, Concerta, Focalin, and Metadate. Amphetamine-based ADHD medicines include those sold under the brand names Adderall, Dextrostat, Dexedrine, and Vyvanse.

The most common side effects associated with stimulant ADD medications include:

  • Insomnia
  • anorexia (decreased appetite)
  • headache
  • jitteriness
  • withdrawal from social activities

These ADHD medication side effects usually do not last long and occur early on in the treatment cycle. Physicians can usually reduce these side effects by adjusting dosage amounts. Many stimulant ADD medications come in extended release or long-acting formulations, allowing one morning dose per day versus the two or more doses per day associated with fast-acting stimulants.

Can Children Become Addicted to Stimulant ADHD Medicines?

Many parents voice concern that their child may become dependant upon stimulant ADHD medicines. Studies have shown that stimulant drugs do not pose a dependency risk when prescribed to children and adolescents to treat ADD. Furthermore, the use of these ADD medications in children and adolescents does not increase potential for drug abuse in adulthood.

That being said, all stimulant drugs, including ADHD medicines, which fall under a controlled substance classification have the potential for abuse. Doctors should not prescribe them to people with a history of substance abuse.

Non-Stimulant ADHD Medications

Physicians now have one FDA approved non-stimulant ADHD drug to add to their arsenal of ADHD medications, atomoxetine, sold under the brand name Strattera. Strattera works to balance levels of norepinephrine in the brain and is effective in reducing ADHD symptoms in children. However, unlike stimulant drugs which affect levels of both norepinephrine and dopamine, patients must take Strattera for a longer period before seeing an improvement in ADHD symptoms.

Strattera does not cause insomnia, nervous tics, headache, or many other possible side effects associated with stimulant ADD medicines. Common side effects include, loss of appetite, nausea, fatigue and possible mood swings. Most of these subside after one or two weeks of consistently taking Strattera. Some experts have reported concerns that long-term use of Strattera can cause growth delays in children and teens. Physicians should monitor growth and weight of patients taking the drug closely.

Choosing Among the ADHD Medications

Studies have shown stimulant ADHD medications as highly effective in controlling ADHD symptoms in children and adolescents. Parents need not worry about their child developing a dependence on these medications if administered properly in the treatment of ADHD. However, certain children do not respond well to any of the stimulant medications, often because they have other disorders in addition to ADHD. In these cases, a non-stimulant drug such as Strattera, may prove the best and most effective choice. Most mental health practitioners suggest including behavior modification therapy for ADD, ADHD children in addition to ADD medicines for optimal success in managing ADHD symptoms and behaviors.

Chemotherapy for Testicular Cancer Causes Long-Term Neurological Damage

Friday, July 20th, 2012

(NaturalNews) The November 25 issue of the Journal of the National Cancer Institute contains a report about the long-term side effects experienced by men who received cisplatin-based chemotherapy for testicular cancer. Severe neurological side effects, discoloration of the hands and feet when exposed to the cold (Raynaud-like phenomena), tinnitus, and impaired hearing were found to be common in men who received chemotherapy as opposed to those who did not.

Men who received cancer treatment between 1980 and 1994 were given follow-up surveys between 1998 and 2002 to assess their conditions after treatment. Researchers found that in the decades following treatment, those men who received any form of chemotherapy were significantly more likely to be experiencing long-term negative side-effects as a result.

In the chemotherapy group, 39 percent of men reported Raynaud-like phenomena, 29 percent reported paresthesias in the hands or feet, 21 percent reported hearing impairment, and 22 percent reported tinnitus symptoms.

Marianne Brydoy, M.D., from Haukeland University’s Department of Oncology in Norway, conducted the study with the help of her colleagues to verify the correlation between high rates of long-term neurological damage and chemotherapy. Since the control groups who did not receive any form of chemotherapy experienced far fewer neurological damage incidents than did those who received chemotherapy, the results are indicative of an underlying problem with chemotherapy treatment.

Experts aim to reassess proper treatments for testicular cancer. They hope to minimize the toxic side effects of chemotherapy by reformulating the levels of cisplatin used in chemotherapy treatment. According to their research, 20 mg/m2 a day is the maximum safe dosage of the drug.

Comments by Mike Adams, the Health Ranger
As this study goes to show, chemotherapy is poison. While chemo may at first appear to be working by shrinking a tumor, it is in fact a systemic poison that will inevitably destroy cells throughout the body, most notably in the brain, heart, liver and kidneys.

The only way to protect yourself from these devastating effects of chemotherapy is to take protective nutritional supplements before undergoing chemo treatments. But oncologists sternly warn patients against consuming such nutritional supplements by citing one of the most oft-repeated myths of the cancer industry: “Nutritional supplements block the chemotherapy” they say!

It’s a lie, of course, but it’s been repeated so frequently by the cancer establishment that they can’t even remember who uttered it first… or why. Truth be told, there is absolutely no science backing up such a false belief. No credible scientific study has ever found that antioxidants or other immune-boosting supplements impede chemotherapy treatments at all. In fact, many supplements potentiate the chemo for cancer cells while simultaneously reducing its toxic effects on healthy cells.

Then again, if cancer doctors knew anything at all about nutrition, they probably wouldn’t be in the business of poisoning people with chemo in the first place.